Redmile Group, LLC Ac Immune Sa Transaction History
Redmile Group, LLC
- $1.28 Billion
- Q4 2024
A detailed history of Redmile Group, LLC transactions in Ac Immune Sa stock. As of the latest transaction made, Redmile Group, LLC holds 1,034,299 shares of ACIU stock, worth $2.69 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
1,034,299
Previous 1,694,167
38.95%
Holding current value
$2.69 Million
Previous $6.4 Million
56.4%
% of portfolio
0.22%
Previous 0.42%
Shares
5 transactions
Others Institutions Holding ACIU
# of Institutions
49Shares Held
27.8MCall Options Held
31.3KPut Options Held
0-
Bvf Inc San Francisco, CA19.5MShares$50.8 Million1.97% of portfolio
-
Black Rock Inc. New York, NY2.61MShares$6.78 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA996KShares$2.59 Million0.0% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C3952KShares$2.48 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny740KShares$1.92 Million0.0% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $217M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...